{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:22:22Z","timestamp":1764174142974},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Science and Technology Plan Project of Guangzhou Municipal College","award":["1201430376"],"award-info":[{"award-number":["1201430376"]}]},{"name":"Technological Innovation Project of Colleges and Universities in Guangdong Province","award":["cx2d1127"],"award-info":[{"award-number":["cx2d1127"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.jpba.2015.04.034","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T18:37:34Z","timestamp":1430591854000},"page":"147-154","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Enantiospecific determination of naftopidil by RRLC\u2013MS\/MS reveals stereoselective pharmacokinetics and tissue distributions in rats"],"prefix":"10.1016","volume":"112","author":[{"given":"Xiawen","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengfeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiewen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2015.04.034_bib0115","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1464-410X.2010.09274.x","article-title":"Benign prostatic hyperplasia: counting the cost of its management","volume":"105","author":"Kirby","year":"2010","journal-title":"BJU Int."},{"key":"10.1016\/j.jpba.2015.04.034_bib0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrurol.2012.192","article-title":"The link between benign prostatic hyperplasia and prostate cancer","volume":"10","author":"\u00d8rsted","year":"2013","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jpba.2015.04.034_bib0125","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.eururo.2008.11.011","article-title":"Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review","volume":"55","author":"Alcaraz","year":"2009","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jpba.2015.04.034_bib0130","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/pros.21003","article-title":"Prostate growth inhibition by subtype-selective alpha1-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia","volume":"69","author":"Kojima","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.jpba.2015.04.034_bib0135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2147\/TCRM.S13883","article-title":"Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia","volume":"7","author":"Masumori","year":"2011","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.jpba.2015.04.034_bib0140","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1464-410X.2006.06030.x","article-title":"Comparison of two \u03b11-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study","volume":"97","author":"Nishino","year":"2006","journal-title":"BJU Int."},{"key":"10.1016\/j.jpba.2015.04.034_bib0145","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/iju.12156","article-title":"Reduction of prostate cancer incidence by naftopidil, an \u03b11-adrenoceptor antagonist and transforming growth factor-beta signaling inhibitor","volume":"20","author":"Yamada","year":"2013","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.jpba.2015.04.034_bib0150","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ijc.23095","article-title":"Naftopidil, a selective \u03b11-adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest","volume":"122","author":"Kanda","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jpba.2015.04.034_bib0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1158\/1940-6207.CAPR-10-0189","article-title":"Naftopidil, a selective \u03b11-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma","volume":"4","author":"Hori","year":"2011","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.jpba.2015.04.034_bib0160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1527-3466.1994.tb00282.x","article-title":"Naftopidil, a novel antihypertensive drug","volume":"12","author":"Himmel","year":"1994","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.jpba.2015.04.034_bib0165","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/bdd.517","article-title":"Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics","volume":"27","author":"Brocks","year":"2006","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jpba.2015.04.034_bib0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1359-6446(03)02904-0","article-title":"Trends in the development of chiral drugs","volume":"9","author":"Caner","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpba.2015.04.034_bib0175","series-title":"FDA'S policy statement for the development of new stereoisomeric drugs","year":"1992"},{"key":"10.1016\/j.jpba.2015.04.034_bib0180","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrd915","article-title":"Putting chirality to work: the strategy of chiral switches","volume":"1","author":"Agranat","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpba.2015.04.034_bib0185","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jchromb.2012.09.021","article-title":"Determination of naftopidil enantiomers in rat plasma using chiral solid phases and pre-column derivatization high-performance liquid chromatography","volume":"907","author":"Liu","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.04.034_bib0190","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/bmc.3112","article-title":"Simultaneous stereoselective analysis of naftopidil and O-desmethyl naftopidil enantiomers in rat feces using an online column switching high performance liquid chromatography method","volume":"28","author":"Zhang","year":"2014","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2015.04.034_bib0195","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.chroma.2014.07.010","article-title":"Effect of particle size on the speed and resolution of chiral separations using supercritical fluid chromatography","volume":"1363","author":"Biba","year":"2014","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2015.04.034_bib0200","first-page":"80","article-title":"Metabolites of R, S-1-(2-methoxyphenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazin in rat plasma","volume":"41","author":"Li","year":"2006","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.jpba.2015.04.034_bib0205","first-page":"335","article-title":"Pharmacokinetic profile of naftopidil in rats","volume":"33","author":"Yu","year":"1998","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.jpba.2015.04.034_bib0210","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.bjp.0706619","article-title":"\u03b11-, \u03b12- and \u03b2-adrenoceptors in the urinary bladder, urethra and prostate","volume":"147","author":"Vrydag","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpba.2015.04.034_bib0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0021-9673(95)00465-3","article-title":"Importance of stereospecific bionalytical monitoring in drug development","volume":"719","author":"Caldwell","year":"1996","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2015.04.034_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-022X(02)00124-0","article-title":"The importance of stereoselective determination of drugs in the clinical laboratory","volume":"54","author":"Rentsch","year":"2002","journal-title":"J. Biochem. Biophys. Methods"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515002678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515002678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T19:51:52Z","timestamp":1537645912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708515002678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":22,"alternative-id":["S0731708515002678"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2015.04.034","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enantiospecific determination of naftopidil by RRLC\u2013MS\/MS reveals stereoselective pharmacokinetics and tissue distributions in rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2015.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}